Mark O Goodarzi Selected Research

Non-alcoholic Fatty Liver Disease

1/2019	Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium.
11/2010	Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark O Goodarzi Research Topics

Disease

47	Insulin Resistance 07/2022 - 06/2003
35	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2005
27	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020 - 01/2005
17	Obesity 01/2022 - 06/2003
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2004
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2003
9	Atherosclerosis 01/2018 - 04/2005
4	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2012
4	Inflammation (Inflammations) 01/2020 - 08/2013
4	Hyperandrogenism 12/2018 - 04/2011
4	Hypertension (High Blood Pressure) 11/2017 - 04/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
3	Chronic Pancreatitis 01/2022 - 01/2021
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2016
3	Infertility (Sterility) 01/2019 - 11/2016
3	Diabetes Mellitus 01/2019 - 08/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 04/2011
3	Neoplasms (Cancer) 10/2016 - 03/2011
2	Prediabetic State (Prediabetes) 07/2022 - 07/2010
2	Lipodystrophy 01/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2019 - 11/2010
2	Hyperinsulinism (Hyperinsulinemia) 11/2017 - 04/2011
2	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2015 - 01/2014
2	Hyperplasia 01/2015 - 01/2003
2	Glucose Intolerance 07/2010 - 08/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Stroke (Strokes) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Critical Illness (Critically Ill) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	COVID-19 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Pancreatic Diseases (Pancreatic Disease) 01/2020
1	Genetic Risk Score 01/2020
1	Disease Progression 01/2020
1	Overweight 12/2019

Drug/Important Bio-Agent (IBA)

43	Insulin (Novolin)FDA Link 07/2022 - 01/2004
42	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2004
16	AndrogensIBA 02/2016 - 01/2003
12	LipidsIBA 01/2022 - 06/2003
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2008
6	Testosterone (Sustanon)FDA Link 01/2022 - 01/2003
6	EnzymesIBA 01/2022 - 07/2007
5	LDL CholesterolIBA 01/2022 - 11/2013
5	AdiponectinIBA 08/2020 - 04/2011
4	GonadotropinsIBA 01/2020 - 08/2015
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2016
4	SteroidsIBA 01/2019 - 04/2007
4	Hormones (Hormone)IBA 01/2019 - 04/2007
4	Blood Glucose (Blood Sugar)IBA 04/2015 - 08/2005
4	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2007 - 07/2003
3	Sex Hormone-Binding GlobulinIBA 01/2022 - 04/2011
3	oxidized low density lipoproteinIBA 01/2020 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 12/2019 - 01/2008
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2016
3	Androgen Receptors (Androgen Receptor)IBA 02/2016 - 05/2008
3	CholesterolIBA 10/2015 - 08/2005
3	Triglycerides (Triacylglycerol)IBA 04/2015 - 11/2013
3	Metformin (Glucophage)FDA LinkGeneric 06/2014 - 11/2005
3	Dehydroepiandrosterone SulfateIBA 07/2008 - 12/2006
2	Estrogen ReceptorsIBA 01/2022 - 11/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 01/2018
2	C-Reactive ProteinIBA 08/2020 - 01/2013
2	Plasminogen Activator Inhibitor 1IBA 08/2020 - 01/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 11/2005
2	Lipoproteins (Lipoprotein)IBA 12/2017 - 11/2013
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 11/2010
2	Hemoglobins (Hemoglobin)IBA 09/2017 - 04/2015
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2016 - 03/2011
2	AcetyltransferasesIBA 01/2016 - 04/2015
2	Genetic Markers (Genetic Marker)IBA 12/2015 - 06/2004
2	Caveolin 1IBA 12/2015 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 07/2010
2	Biological ProductsIBA 09/2015 - 04/2008
2	Insulin ReceptorIBA 08/2015 - 04/2011
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2015 - 04/2007
2	CatecholaminesIBA 06/2014 - 12/2010
2	HDL CholesterolIBA 11/2013 - 04/2013
2	Glycogen Synthase KinasesIBA 04/2011 - 06/2007
2	3 (or 17)-beta-hydroxysteroid dehydrogenaseIBA 12/2009 - 01/2008
2	Glycogen Synthase Kinase 3 betaIBA 12/2008 - 06/2007
2	Dehydroepiandrosterone (DHEA)IBA 07/2007 - 04/2007
1	AntioxidantsIBA 03/2022
1	NucleotidesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	ProinsulinIBA 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2020
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Benzoates (Benzoate)IBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	XanthineIBA 01/2019

Therapy/Procedure

2	Glycemic Control 01/2022 - 09/2017
2	Therapeutics 01/2017 - 11/2005
1	Dietary Approaches To Stop Hypertension 01/2022